Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4335 studies found for:    Japan
Show Display Options
Rank Status Study
1 Not yet recruiting Treatment Pattern of Oral Anticoagulants (OAC) in Japan
Condition: Atrial Fibrillation
2 Recruiting The Effects of Seasonal Changes in Osteoporosis Treatment
Condition: Selective Estrogen Receptor Modulator (SERM)
Intervention: Drug: Raloxifene
3 Recruiting EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge
Condition: Endoscopic Ultrasonography-guided Fine Needle Aspiration
Intervention: Procedure: Endoscopic ultrasonography-guided fine needle aspiration
4 Recruiting Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK2269557 ELLIPTA DPI;   Drug: Placebo ELLIPTA DPI
5 Recruiting Trial of MiStent Compared to Xience in Japan
Condition: Coronary (Artery); Disease
Interventions: Device: MiStent (MT005) Coronary Artery Stent;   Device: Xience Coronary Artery Stent
6 Recruiting Safety Study of BMS-986016 With or Without Nivolumab in Subjects With Advanced Solid Tumors
Condition: Cancer
Interventions: Drug: BMS-986016;   Drug: Nivolumab
7 Recruiting A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
Condition: Migraine
Interventions: Drug: Galcanezumab;   Drug: Placebo
8 Recruiting Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers
Condition: Influenza
Interventions: Biological: NSV0001;   Biological: Influenza HA vaccine "Biken HA";   Biological: Placebo
9 Recruiting Phase 1 Study of GSK2315698 in Healthy Japanese Subjects
Condition: Amyloidosis
Interventions: Drug: Placebo;   Drug: GSK2315698
10 Recruiting Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
Conditions: Gastric Cancer;   Esophageal Cancer;   Lung Cancer;   Renal Cancer
Interventions: Biological: Mogamulizumab;   Biological: Nivolumab
11 Not yet recruiting Drug Use Investigation of Kovaltry in Hemophilia A Patients
Condition: Hemophilia A
Intervention: Drug: Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973)
12 Recruiting Endoscopic Evaluation for Predicting the Complications Related to Gastric Conduit After Esophagectomy
Conditions: Esophageal Neoplasms;   Constriction;   Anastomotic Leak;   Ischemia
Intervention: Procedure: Patients after esophagectomy
13 Completed Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects
Condition: Healthy
Interventions: Drug: PF-06650833;   Drug: placebo
14 Enrolling by invitation A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects
Condition: Healthy Volunteer
Interventions: Drug: DMB-3113;   Drug: Adalimumab
15 Active, not recruiting A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Condition: Multiple Myeloma
16 Active, not recruiting A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Condition: Multiple Myeloma
17 Active, not recruiting A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment
Conditions: Myelodysplastic Syndromes;   Leukemia, Myeloid, Acute
18 Active, not recruiting A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Conditions: Multiple Myeloma;   Myelodysplastic Syndromes
19 Not yet recruiting HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
20 Recruiting A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
Condition: Anemia
Intervention: Drug: JR-131

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.